Program Overview:
The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication, and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries.
WJCF is an Indian not-for-profit entity, registered under Section 8 of the Indian Companies Act 2013, and has an affiliation agreement with the Clinton Health Access Initiative (CHAI). Our mission is to save lives and improve health outcomes in the country by enabling the government and private sector to strengthen and sustain quality health systems. WJCF has partnered with the Ministry of Health & Family Welfare and state health departments since 2007, providing technical and operational support across key health priorities, including infectious diseases (COVID-19, hepatitis, HIV, TB, vector-borne diseases), non-communicable diseases (cervical cancer, diabetes, sickle cell disease), maternal and child health (anaemia, immunisation, diarrhoea, pneumonia), sexual and reproductive health, health insurance and digital health (AB PM-JAY, ABDM), oxygen and hypoxemia management, safe drinking water, and climate and health.
Learn more about our exciting work: http://www.clintonhealthaccess.org
Th
Project Overview:
Despite India’s rapid growth in digital adoption and e-commerce, the sexual and reproductive health (SRH) space remains relatively nascent online, with contraception and fertility products accounting for only ~$4.23M of the digital health market. At the same time, significant gaps persist: the unmet need for family planning among married women stands at 8.5%, and modern contraceptive use has actually declined (from 56.4% to 52.7%), pointing to continued unmet demand for trustworthy information and access (NFHS-6, 2023–24). While users seeking FP-SRH information prefer a discreet, trustworthy path from awareness to action, the same is not achievable through traditional clinic-based counselling models and as a consequence, users often turn to digital channels where they encounter fragmented, stigmatising, or unreliable content. There is, therefore, a need for digital platforms which can offer comprehensive and reliable information.
Since 2024, WJCF has deepened its focus on Alternative Service Delivery (ASD), i.e., identifying, testing, and scaling non-traditional channels, beyond public health facilities and frontline workers, through which underserved populations can access SRH products, services, and information.
Our hypothesis is twofold. First, there is significant unmet demand for reliable, accessible FP-SRH information, and authoritative, cohort-tailored digital content can measurably shift awareness. Second, when users are offered trustworthy, stigma-free content alongside a discreet, low-friction path to purchase or counselling on platforms they already use, a meaningful share will convert from awareness to action — i.e., verified uptake of FP-SRH products and services.
Our ASD work began with a structured landscaping exercise that reviewed 56 service delivery and demand generation models across health and non-health sectors in India and globally, identifying digital and private-sector channels with the strongest potential for reach, cost-effectiveness, and scalability.
This approach was validated through a 2025 pilot with a leading e-pharmacy partner. WJCF co-designed and ran a 4-month, multi-channel FP-SRH demand-generation campaign which reached 0.98M users and achieved a ~3% reach-to-conversion rate among new-to-category buyers. Monthly SRH purchasers rose ~62% over the pre-pilot baseline – 64% of them new to the category – with growth across priority products (condoms +51%, ECPs +48%, and OCPs +57%). Average time on the campaign microsite was ~4 minutes against a ~1-minute benchmark, signalling strong content engagement.
Building on this foundation, WJCF has secured a multi-year grant to scale and diversify its digital SRH work across two parallel workstreams: one that deepens and scales e-pharmacy partnerships into a structured, ongoing test-and-learn engine to drive users to category adoption, and another that expands into additional digital ecosystems to identify which channels can reliably move users from awareness to verified uptake, and overall, understanding the conditions under which such partnerships can become self-sustaining with reduced donor support.
Position Overview:
WJCF is seeking a highly motivated Associate to lead analytical, strategic, and implementation workstreams for our ASD work. The Associate will drive high-quality analyses, design frameworks for intervention models, lead research activities, and manage relationships with donors and partners across digital ecosystems (e-pharmacy, e-commerce, and other consumer platforms). They will guide components of program execution, develop strategic documentation, and ensure delivery of key outputs. The role requires strong problem-solving and stakeholder management abilities, comfort working in complex environments, and the ability to independently own and drive major workstreams.
Advantages:
Last Date to Apply: 29th July, 2026
Software Powered by iCIMS
www.icims.com